QSIAW
Quantum-Si incorporatedNASDAQ
Key Statistics
Market Cap
$1.44B
P/E Ratio
—
EPS
—
Beta
3.09
52W High
$1.08
52W Low
$0.08
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Quantum-Si incorporated
Quantum-Si Incorporated is a pioneering life sciences technology company focused on revolutionizing protein sequencing through its proprietary single-molecule technology coupled with advanced quantum dot capabilities. By delivering high-throughput and cost-effective sequencing solutions, Quantum-Si enhances protein analysis, driving significant advancements in genomics and personalized medicine. With a robust intellectual property portfolio and a commitment to advancing biological research, the company is uniquely positioned to capitalize on the growing demand for cutting-edge sequencing technologies in academic and clinical settings.
Fundamentals
| Revenue (TTM) | $2.44M |
| Gross Profit (TTM) | $1.15M |
| EBITDA | $-92.59M |
| Operating Margin | -4677.00% |
| Return on Equity | -46.50% |
| Return on Assets | -24.60% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $1.02 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -62.20% |
| Shares Outstanding | 0 |
| Float | $178.30M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/9/2026